| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/20/2023 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 35.9k | $0.47 | $16.8k | | 01/20/2023 |
| 10/04/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 346 | $0.57 | $197.2 | | 10/04/2022 |
| 09/26/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 18.9k | $0.55 | $10.4k | | 09/26/2022 |
| 06/09/2022 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 20k | $1.65 | $33k | | 06/09/2022 |
| 02/18/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 1000 | $4.30 | $4.3k | | 02/14/2022 |
| 02/14/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 2k | $4.45 | $8.9k | | 02/14/2022 |
| 02/09/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 1000 | $4.75 | $4.8k | | 02/08/2022 |
| 02/08/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 1000 | $4.92 | $4.9k | | 02/08/2022 |
| 02/04/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 1000 | $5.00 | $5k | | 02/03/2022 |
| 02/03/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 5k | $5.15 | $25.8k | | 02/03/2022 |
| 01/27/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 5k | $5.30 | $26.5k | | 01/27/2022 |
| 10/08/2021 | PHOENIX BIOTECH ACQUISITION CORP. | | Other (acquisition) | Class A common stock | 36.7k | $10.00 | $367.3k | By Phoenix Biotech Sponsor, LLC | 10/08/2021 |
| 10/08/2021 | PHOENIX BIOTECH ACQUISITION CORP. | | Other (disposition) | Class B Common Stock | 82.9k | $0.00 | $0 | By Phoenix Biotech Sponsor, LLC | 10/08/2021 |
| 10/08/2021 | PHOENIX BIOTECH ACQUISITION CORP. | | Other (acquisition) | Warrants | 18.4k | $11.50 | $211.2k | By Phoenix Biotech Sponsor, LLC | 10/08/2021 |
| 10/06/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 40k | $11.36 | $454.4k | | 10/06/2021 |
| 08/25/2021 | eFFECTOR Therapeutics, Inc. | | Conversion | Class B Common Stock | 1k | $0.00 | $0 | By Locust Walk Partners LLC | 08/25/2021 |
| 08/25/2021 | eFFECTOR Therapeutics, Inc. | | Disposition | Class B Common Stock | 966 | $0.00 | $0 | By Locust Walk Partners LLC( | 08/25/2021 |
| 08/25/2021 | eFFECTOR Therapeutics, Inc. | | Conversion | Class B Common Stock | 142.2k | $0.00 | $0 | By Locust Walk Partners LLC | 08/25/2021 |
| 08/25/2021 | eFFECTOR Therapeutics, Inc. | | Disposition | Class B Common Stock | 132.8k | $0.00 | $0 | By Locust Walk Partners LLC | 08/25/2021 |
| 08/25/2021 | eFFECTOR Therapeutics, Inc. | | Conversion | Common Stock | 1k | $0.00 | $0 | By Locust Walk Partners LLC | 08/25/2021 |
| 08/25/2021 | eFFECTOR Therapeutics, Inc. | | Conversion | Common Stock | 142.2k | $0.00 | $0 | By Locust Walk Partners LLC | 08/25/2021 |
| 01/12/2021 | eFFECTOR Therapeutics, Inc. | | Other (disposition) | Class B Common Stock | 23.8k | $0.00 | $0 | By Locust Walk | 01/12/2021 |
| 04/10/2013 | Paratek Pharmaceuticals, Inc. | PRTK | Grant | Common Stock Option (right to buy) | 13.5k | $4.76 | $64.3k | | 04/10/2013 |
| 02/03/2010 | Paratek Pharmaceuticals, Inc. | PRTK | Grant | Common Stock Option (right to buy) | 1.9k | $8.07 | $15.3k | | 02/03/2010 |
| 01/14/2010 | Paratek Pharmaceuticals, Inc. | PRTK | Grant | Common Stock Option (right to buy) | 4k | $8.21 | $32.8k | | 01/14/2010 |